1-5 of 5
Kai Li
Close
Sort by
Journal Articles

A Phase 2/3, Multicenter Randomized Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) with or without Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR DLBCL)

Seung Tae Lee, Antonio Pinto, Habte Yimer, Don Stevens, Wanda Knopinska Posluszny, Merrill Kingman Shum, Sudhir Manda, Merav Leiba, Miguel Canales, Maciej Kaźmierczak, Wojciech Jurczak, Anna Sureda, Xiwen Ma, Kai Li, Kimberly Ingalls, Tara Arriola, Melina Arazy, Jatin J. Shah, Sharon Shacham, Michael G. Kauffman, Grzegorz S. Nowakowski
Journal: Blood
Blood (2021) 138 (Supplement 1): 1420.
https://doi.org/10.1182/blood-2021-150025
Published: 2021
Journal Articles

A Novel Approach to Assess Capacities of Red Cells in Dissolving Oxygen and Carrying Oxygen Based on a Portable Near-Infrared Spectroscopy Device

Ting Li, PhD, Yue Zhao, Master, Yunlong Sun, Master, Kai Li, Master, Wenjie Li, Meixue Duan, PhD, Chenyang Gao, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4792.
https://doi.org/10.1182/blood-2019-124003
Published: 2019
Journal Articles

Developing a Novel Class of Drug to Inhibit Protein Arginine Methyltransferase 5 (PRMT5) Enzyme Dysregulation in Mantle Cell Lymphoma

Fengting Yan, M.D., Ph.D., Porsha Smith, Lapo Alinari, MD., Ph.D., John Ryu, Bo Yu, Ph.D., Vrajesh Karkhanis, Ph.D., Sookil Tae, Ph.D., John T. Patton, Emily E. Wilding, Kate Gordon, Kiran Mahasenan, Ph.D., Deepak Bhasin, Ph.D., Claudio Agostinelli, M.D., Ph.D., Stefano A. Pileri, M.D., John C. Byrd, MD, Said Sif, Ph.D., Pui-kai Li, Ph.D., Chenglong Li, Ph.D., Robert A. Baiocchi, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 595.
https://doi.org/10.1182/blood.V118.21.595.595
Published: 2011
Journal Articles

Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice

Bihui Huang, Arun B. Deora, Kai-Li He, Kang Chen, Guangzhi Sui, Andrew T. Jacovina, Dena Almeida, Peng Hong, Paul Burgman, Katherine A. Hajjar
Journal: Blood
Blood (2011) 118 (10): 2918–2929.
https://doi.org/10.1182/blood-2011-03-341214
Published: 2011
Includes: Supplemental data
Journal Articles

Use of Arsenic Trioxide (As 2 O 3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): I. As 2 O 3 Exerts Dose-Dependent Dual Effects on APL Cells

Guo-Qiang Chen, Xue-Geng Shi, Wei Tang, Shu-Min Xiong, Jun Zhu, Xun Cai, Ze-Guang Han, Jian-Hua Ni, Gui-Ying Shi, Pei-Ming Jia, Meng-Min Liu, Kai-Li He, Chao Niu, Jun Ma, Peng Zhang, Ting-Dong Zhang, Pascale Paul, Tomoki Naoe, Kunio Kitamura, Wilson Miller, Samuel Waxman, Zhen-Yi Wang, Hugues de The, Sai-Juan Chen, Zhu Chen
Journal: Blood
Blood (1997) 89 (9): 3345–3353.
https://doi.org/10.1182/blood.V89.9.3345
Published: 1997